DPS Biometics Expands Presence in Massachusetts to Accommodate Growth

FRAMINGHAM, MA--(Marketwire - May 16, 2011) - Last week, DPS Biometics hosted an open-house for State and local officials, as well as employees and members of the Irish Government at its new Framingham facility. The event marked the latest development for the Ireland-based provider of architectural, engineering and validation services to the pharmaceutical and biotechnology sectors. Earlier this year, the company planted roots in the region by acquiring Biometics, a local engineering consulting firm with a biotech specialty. The new Framingham facility will accommodate the company's fast-growing workforce which is expected to triple over the next two years.

Calling the new facility a major investment and a cornerstone of the company's growth strategy, DPS Engineering CEO Frank Keogh said, "Massachusetts is well known for its innovation culture and its world-class graduates. With these attributes and our talented local employees, we can continue to deliver high-value services to existing and new customers."

On hand at the event was Massachusetts State representative, Chris Walsh, who cited the new facility as a "strategically important investment for DPS, founded on the wealth of biopharmaceutical talent in the New England area."

Dr. Susan Windham-Bannister, President and CEO of the Massachusetts Life Sciences Center, spoke of the importance of companies like DPS Biometics in supporting the aims of the 10-year $1 billion state initiative to grow the Massachusetts Life Sciences Super-Cluster. "DPS will find the MetroWest region to be a great place to do business, as this is a region where the life sciences are thriving. This growth is facilitated by a cluster of exceptional service providers, like DPS, that can facilitate company expansions throughout our state."

Michael Lonergan the Irish Consul General to Boston credited the DPS Biometics team for creating a strong combined entity that promises job growth and provides even greater value to customers. "DPS Biometics is the latest Ireland-based company with ambitious expansion plans in New England. Today, more than 82,000 Americans are employed by Irish companies -- almost as many Irish people that are employed by US companies in Ireland. We're delighted to see the company expand. It's good for Massachusetts and good for Ireland."

The DPS Biometics team is currently executing full multi-disciplinary architectural/engineering design for the new University of Massachusetts - Dartmouth, $23m Greenfield Bioprocessing facility which will be the anchor tenant in the new Bio-Park in Fall River, MA.

DPS Engineering employs more than 400 people worldwide in locations that include Ireland, the Netherlands, Singapore and the Middle East. Clients include Pfizer, Eli Lilly, J&J and Genzyme, among many others. The company is supported in its US market efforts by Enterprise Ireland, the government organization responsible for the development and growth of Irish enterprises in world markets.

To learn more about DPS Biometics, please visit www.biometicsma.com
To learn more about Enterprise Ireland, please visit www.enterprise-ireland.com